Skip to content

Rigel Pharmaceuticals RIGL Single reportable segment — Net Income

Similar metrics at other companies

OppFi logo
OPFIReportable Segment — Net Income
$54.04M+165%
SandRidge Energy logo
SDReportable Segment — Net Income
$18.67M+43.1%
Fulton Financial logo
FULTReportable Segment — Net Income
$97.9M+35.6%
Indivior Pharmaceuticals, Inc.
 logo
INDVReportable Segment — Net Income
$89M+89.4%
Shift4 Payments logo
FOURReportable Segment — Net Income
$12M-40.0%
Grindr logo
GRNDReportable Segment — Net Income
$26.75M-1.0%

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's single reportable segment — net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's single reportable segment — net income?
Rigel Pharmaceuticals (RIGL) reported single reportable segment — net income of $8.65M in Q1 2026.
What does single reportable segment — net income mean?
Calculated as the total revenue minus all operating expenses, taxes, and interest costs for the reportable segment. This is the primary measure of the segment's overall financial health and profitability.